Cargando…
IVIg Treatment Reduces Catalytic Antibody Titers of Renal Transplanted Patients
Catalytic antibodies are immunoglobulins endowed with enzymatic activity. Catalytic IgG has been reported in several human autoimmune and inflammatory diseases. In particular, low levels of catalytic IgG have been proposed as a prognostic marker for chronic allograft rejection in patients undergoing...
Autores principales: | Mahendra, Ankit, Peyron, Ivan, Dollinger, Cécile, Gilardin, Laurent, Sharma, Meenu, Wootla, Bharath, Padiolleau-Lefevre, Séverine, Friboulet, Alain, Boquet, Didier, Legendre, Christophe, Kaveri, Srinivas V., Thaunat, Olivier, Lacroix-Desmazes, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744545/ https://www.ncbi.nlm.nih.gov/pubmed/23967092 http://dx.doi.org/10.1371/journal.pone.0070731 |
Ejemplares similares
-
Structural and Functional Mise en Abyme
por: Avalle, Bérangère, et al.
Publicado: (2019) -
Complement C3 is a novel modulator of the anti-factor VIII immune response
por: Rayes, Julie, et al.
Publicado: (2018) -
Relevance of the Materno-Fetal Interface for the Induction of Antigen-Specific Immune Tolerance
por: Mimoun, Angelina, et al.
Publicado: (2020) -
Autoimmunity as a Predisposition for Infectious Diseases
por: Maddur, Mohan S., et al.
Publicado: (2010) -
The ADAMTS13(1239–1253) peptide is a dominant HLA-DR1-restricted CD4(+) T-cell epitope
por: Gilardin, Laurent, et al.
Publicado: (2017)